Canada Life
ADPT icon

Canada Life’s Adaptive Biotechnologies ADPT Stock Holding History

Canada Life’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
14,003
+4,348
+45% +$66.6K ﹤0.01% 1550
2026
Q1 		$135K Hold
9,655
– – ﹤0.01% 1653
2025
Q4 		$157K Sell
9,655
-20,814
-68% -$340K ﹤0.01% 1657
2025
Q3 		$410K Buy
30,469
+4,552
+18% +$55.5K ﹤0.01% 1632
2025
Q2 		$302K Buy
25,917
+16,262
+168% +$148K ﹤0.01% 1673
2025
Q1 		$72K Buy
+9,655
New +$74.2K ﹤0.01% 1824
2024
Q2 		– Sell
-12,950
Closed -$41K – 2097
2024
Q1 		$41K Sell
12,950
-49,144
-79% -$190K ﹤0.01% 2035
2023
Q4 		$302K Sell
62,094
-2,024
-3% -$9.23K ﹤0.01% 1784
2023
Q3 		$348K Buy
64,118
+8,313
+15% +$55K ﹤0.01% 1764
2023
Q2 		$376K Buy
55,805
+22,384
+67% +$166K ﹤0.01% 1747
2023
Q1 		$295K Sell
33,421
-6,387
-16% -$56.3K ﹤0.01% 1812
2022
Q4 		$305K Buy
39,808
+18,489
+87% +$144K ﹤0.01% 1815
2022
Q3 		$152K Buy
21,319
+16,682
+360% +$157K ﹤0.01% 1919
2022
Q2 		$38K Hold
4,637
– – ﹤0.01% 2108
2022
Q1 		$68K Hold
4,637
– – ﹤0.01% 2088
2021
Q4 		$130K Sell
4,637
-733
-14% -$22.5K ﹤0.01% 1952
2021
Q3 		$183K Hold
5,370
– – ﹤0.01% 1917
2021
Q2 		$220K Hold
5,370
– – ﹤0.01% 1907
2021
Q1 		$215K Sell
5,370
-797
-13% -$43.1K ﹤0.01% 1932
2020
Q4 		$363K Buy
6,167
+1,055
+21% +$54.4K ﹤0.01% 1828
2020
Q3 		$248K Hold
5,112
– – ﹤0.01% 1843
2020
Q2 		$246K Buy
+5,112
New +$186K ﹤0.01% 1860

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Canada Life's ADPT Position: Q2 2026 in Review

Canada Life increased its Adaptive Biotechnologies (ADPT) stake by 45% in Q2 2026, buying an estimated $66.6K and bringing the position to 14,003 shares worth $300K. The position accounts for ﹤0.01% of the portfolio, ranked #1550.

Canada Life first reported a position in ADPT in Q2 2020 and has held it in 22 quarters since. The position peaked at $410K in Q3 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Canada Life held 14,003 shares of Adaptive Biotechnologies worth $300K as of Q2 2026.
  • Canada Life bought 4,348 Adaptive Biotechnologies shares in Q2 2026, an estimated $66.6K.
  • Adaptive Biotechnologies made up ﹤0.01% of Canada Life's portfolio in Q2 2026, its #1550 holding.
  • Canada Life first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 22 quarters since.
  • Canada Life's Adaptive Biotechnologies position peaked at $410K in Q3 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Canada Life's 13F filing for Q2 2026, filed 13 Aug 2026.